​

CARGO Therapeutics (CRGX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

CRGX Stock Forecast

CARGO Therapeutics (CRGX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $7.00, with a high of $7.00 and a low of $7.00. This represents a 50.86% increase from the last price of $4.64.

- $5 $10 $15 $20 $25 High: $7 Avg: $7 Low: $7 Last Closed Price: $4.64

CRGX Stock Rating

CARGO Therapeutics stock's rating consensus is Hold, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 0 Buy (0.00%), 6 Hold (85.71%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Hold
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

CRGX Price Target Upside V Benchmarks

TypeNameUpside
StockCARGO Therapeutics50.86%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts-15
Avg Price Target-$7.00$27.60
Last Closing Price$4.64$4.64$4.64
Upside/Downside-50.86%494.83%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25--5-16
Mar, 25-17-19
Feb, 25-16-18
Jan, 25353--11
Dec, 2435---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 30, 2025Asthika GoonewardeneTruist Financial$7.00$13.19-46.93%50.86%
Sep 12, 2024Biren AminPiper Sandler$34.00$22.1853.29%632.76%
Jul 08, 2024Geulah LivshitsLoop Capital Markets$28.00$16.0075.00%503.45%
Jun 27, 2024Biren AminPiper Sandler$37.00$14.60153.42%697.41%
May 16, 2024Asthika GoonewardeneTruist Financial$32.00$20.9952.45%589.66%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 30, 2025H.C. WainwrightNeutraldowngrade
Jan 30, 2025William BlairMarket Performdowngrade
Jan 30, 2025Piper SandlerOverweightNeutraldowngrade
Jan 30, 2025JefferiesHolddowngrade
Sep 12, 2024Piper SandlerOverweightOverweighthold
Jul 08, 2024Chardan CapitalBuyinitialise
Jun 27, 2024Piper SandlerOverweightinitialise

Financial Forecast

EPS Forecast

$-70 $-56 $-42 $-28 $-14 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.38$-3.72----
Avg Forecast$-22.47$-3.68$-4.01$-3.80$-2.58$-1.57
High Forecast$-3.45$-3.51$-3.07$-2.39$-0.74$-1.57
Low Forecast$-65.39$-3.85$-4.75$-4.81$-5.29$-1.57
Surprise %-89.41%1.09%----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$625.00K$42.71M$204.24M$341.99M
High Forecast--$625.00K$44.33M$209.16M$341.99M
Low Forecast--$625.00K$41.09M$199.32M$341.99M
Surprise %------

Net Income Forecast

$-3B $-2B $-2B $-1B $-600M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-98.15M$-167.50M----
Avg Forecast$-1.42B$-154.14M$-161.16M$-148.34M$-152.97M$-64.49M
High Forecast$-142.10M$-144.82M$-126.60M$-98.34M$-30.38M$-64.49M
Low Forecast$-2.69B$-158.65M$-195.72M$-198.33M$-217.83M$-64.49M
Surprise %-93.08%8.67%----

CRGX Forecast FAQ

Is CARGO Therapeutics stock a buy?

CARGO Therapeutics stock has a consensus rating of Hold, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 0 Buy, 6 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that CARGO Therapeutics is a neutral investment for most analysts.

What is CARGO Therapeutics's price target?

CARGO Therapeutics's price target, set by 7 Wall Street analysts, averages $7 over the next 12 months. The price target range spans from $7 at the low end to $7 at the high end, suggesting a potential 50.86% change from the previous closing price of $4.64.

How does CARGO Therapeutics stock forecast compare to its benchmarks?

CARGO Therapeutics's stock forecast shows a 50.86% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for CARGO Therapeutics over the past three months?

  • April 2025: 0% Strong Buy, 0% Buy, 83.33% Hold, 0% Sell, 16.67% Strong Sell.
  • March 2025: 0% Strong Buy, 11.11% Buy, 77.78% Hold, 0% Sell, 11.11% Strong Sell.
  • February 2025: 0% Strong Buy, 12.50% Buy, 75.00% Hold, 0% Sell, 12.50% Strong Sell.

What is CARGO Therapeutics’s EPS forecast?

CARGO Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-4.01, marking a 7.80% increase from the reported $-3.72 in 2024. Estimates for the following years are $-3.8 in 2026, $-2.58 in 2027, and $-1.57 in 2028.

What is CARGO Therapeutics’s revenue forecast?

CARGO Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $625K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $42.71M, followed by $204.24M for 2027, and $341.98M for 2028.

What is CARGO Therapeutics’s net income forecast?

CARGO Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-161M, representing a -3.79% decrease from the reported $-168M in 2024. Projections indicate $-148M in 2026, $-153M in 2027, and $-64.487M in 2028.